Marie Thibault

Anthony Petrone

Mathew Blackman

Matthew Taylor

Sam Eiber

Vernon Bernardino

- Senseonics Holdings, Inc. filed a Certificate of Amendment on **October 16, 2025**, to implement a **one-for-twenty (1-for-20) reverse stock split** of its common stock.  **[1616543_0001104659-25-100097_tm2528782d1_8k.htm:1]** 
- The reverse stock split will be **effective at 4:05 p.m. Eastern Time on October 17, 2025**, and the common stock is expected to begin trading on a split-adjusted basis on the NYSE American on **October 20, 2025**.  **[1616543_0001104659-25-100097_tm2528782d1_8k.htm:1]** **[1616543_0001104659-25-100097_tm2528782d1_ex3-1.htm:2]** 
- Concurrently, the total number of authorized common shares will be reduced from **1,400,000,000 to 70,000,000**.  **[1616543_0001104659-25-100097_tm2528782d1_8k.htm:1]** 
- No fractional shares will be issued; instead, stockholders entitled to fractional shares will receive a **cash payment**.  **[1616543_0001104659-25-100097_tm2528782d1_8k.htm:1]** **[1616543_0001104659-25-100097_tm2528782d1_ex3-1.htm:1]**

Senseonics Holdings, Inc. to Implement 1-for-20 Reverse Stock Split

- Senseonics Holdings, Inc. reported **preliminary unaudited revenue of $8.1 million** for the third quarter of 2025, marking a **91% increase** compared to Q3 2024.  **[1616543_0001104659-25-097124_tm2528088d1_e99-1.htm:0]** 
- This revenue growth was driven by approximately **160% new patient growth** in the U.S. over the prior year, resulting in record quarterly new patient starts.  **[1616543_0001104659-25-097124_tm2528088d1_e99-1.htm:0]** 
- The company announced a **one-for-twenty (1:20) reverse stock split**, anticipated to be effective on **October 17, 2025**, with post-split trading commencing on **October 20, 2025**.  **[1616543_0001104659-25-097124_tm2528088d1_e99-1.htm:0]** 
- This reverse stock split will reduce the number of outstanding common shares from approximately **816 million** to approximately **41 million**.  **[1616543_0001104659-25-097124_tm2528088d1_e99-1.htm:0]**

Senseonics Reports Preliminary Q3 2025 Revenue and Announces Reverse Stock Split

- Senseonics reported **preliminary unaudited revenue of $8.1 million** for the third quarter of 2025.  **[1616543_1983ebcf21a24082af0a67a27399a56f_0]** 
- This represents a **91% increase** in revenue compared to the third quarter of 2024, primarily driven by approximately **160% new patient growth** in the U.S..  **[1616543_1983ebcf21a24082af0a67a27399a56f_0]** 
- The company will conduct a **1:20 reverse stock split**, anticipated to be effective on **October 17, 2025**, with post-split trading beginning on **October 20, 2025**.  **[1616543_1983ebcf21a24082af0a67a27399a56f_0]** 
- This reverse stock split will reduce the number of outstanding shares from approximately **816 million to 41 million**.  **[1616543_1983ebcf21a24082af0a67a27399a56f_0]**

Senseonics Holdings (SENS)